Morgan Stanley »

Verve Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.9M 296k 13.26
2023-06-30 $6.4M 342k 18.80
2022-12-31 $1.9M 97k 19.35
2022-06-30 $3.7M 198k 18.52
2022-03-31 $4.9M 217k 22.82
2021-06-30 $149k 2.5k 60.37